Differences

This shows you the differences between two versions of the page.

--- lucia_zhang [2023/05/27 07:52]
liam
+++ lucia_zhang [2023/11/07 18:46] (current)
liam
@@ Line 4: / Line 4: @@
 **Lucia Zhang** is a Canadian regulatory official based in [[canada:ontario:Ottawa]], [[canada:Ontario]]. She is a Senior Clinical Evaluator at [[Health Canada]]'s [[Biologic and Radiopharmaceutical Drugs Directorate]] (BRDD).((//Lucia Zhang.// LinkedIn. Retrieved May 27, 2023, from http://archive.today/2023.05.27-053527/https://www.linkedin.com/in/lucia-zhang-53143226/)) ((//Lucia Zhang · Health Canada · Clinical Evaluator.// OpenGovCa. Retrieved May 27, 2023, from https://web.archive.org/web/20230527053643/https://opengovca.com/employee/lucia-zhang))
+She is a member of the [[American Society for Pharmacology and Experimental Therapeutics]] (ASPET) and the [[American Society for Bone and Mineral Research]] (ASBMR).((//Organizations | Lucia Zhang.// LinkedIn. Retrieved May 27, 2023, from https://www.linkedin.com/in/lucia-zhang-53143226/details/organizations/))
 ===== History =====
+Zhang's hometown is [[canada:alberta:Edmonton]], [[canada:Alberta]].((//Lucia Zhang - Pharmacology and Toxicology.// University of Toronto. Retrieved May 27, 2023, from https://web.archive.org/web/20230527055815/https://glse.utoronto.ca/lucia-zhang-pharmacology-and-toxicology))
 ==== Education ====
-Zhang attended the [[University of Toronto]] from September 2009 to June 2013 for her Bachelor of Science in Pharmacology and Toxicology, and September 2013 to June 2018 for her Doctor of Philosophy in Pharmacology.((//Lucia Zhang.// LinkedIn. Retrieved May 27, 2023, from http://archive.today/2023.05.27-053527/https://www.linkedin.com/in/lucia-zhang-53143226/)) She worked as as Summer Intern at [[National Research Council Canada]] (NRC) from May to August 2010.
+Zhang attended the [[University of Toronto]] from September 2009 to June 2013 for her Bachelor of Science in Pharmacology and Toxicology, and September 2013 to June 2018 for her Doctor of Philosophy in Pharmacology.((//Lucia Zhang.// LinkedIn. Retrieved May 27, 2023, from http://archive.today/2023.05.27-053527/https://www.linkedin.com/in/lucia-zhang-53143226/)) She worked as as Summer Intern at [[National Research Council Canada]] (NRC) from May to August 2010. She served in several roles at the [[Pharmacology and Toxicology Students' Association]] and the [[Pharmacology Graduate Students' Association]].((//VIP 2018 Abstract Booklet.// University of Toronto. Retrieved May 27, 2023, from https://web.archive.org/web/20230528054627/https://pharmtox.utoronto.ca/sites/default/files/VIP%202018%20Booklet%20Final.pdf))
+Zhang conducted research in the [[Grynpas Lab]] at the [[Lunenfeld-Tanenbaum Research Institute]].((//Lucia Zhang | Dr. Marc Grynpas.// Lunenfeld-Tanenbaum Research Institute. Retrieved May 28, 2023, from http://archive.today/2023.05.28-053645/https://research.lunenfeld.ca/grynpas/Default.asp?page=lucia-zhang)) She volunteered at [[Toronto Western Hospital]] from September 2012 to June 2013.
 ==== Career ====
-She volunteered at [[Toronto Western Hospital]] from September 2012 to June 2013.
+Zhang began work at [[Health Canada]] as a Clinical Evaluator in June 2018.
+=== COVID-19 ====
+Zhang participated in the 14th [[Workshop on Recent Issues in Bioanalysis]] from June 15-29, 2020. The conference was partnered with the [[Future Science Group]] (FSG).
+On February 2021, the journal //[[journals:Bioanalysis]]// published a paper co-authored by Zhang titled //2020 White Paper on Recent Issues in
+Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation (Part 3 – Recommendations on Immunogenicity Assay Strategies, NAb Assays, Biosimilars and FDA/EMA Immunogenicity Guidance/Guideline, Gene & Cell Therapy and Vaccine Assays).//((Corsaro, B., Yang, T.-Y., Murphy, R., Sonderegger, I., Exley, A., Bertholet, S., Dakappagari, N., Dessy, F., Garofolo, F., Kierstead, L., Koch, H., Sarikonda, G., Savoie, N., Siggers, R., Solstad, T., Lu, Y., Milton, M., Marshall, J.-C., DelCarpini, J., & Gorovits, B. (2021). //2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation (Part 3 - Recommendations on Immunogenicity Assay Strategies, NAb Assays, Biosimilars and FDA/EMA Immunogenicity Guidance/Guideline, Gene & Cell Therapy and Vaccine Assays).// Bioanalysis, 13(6), 415–463. https://doi.org/10.4155/bio-2021-0007))  Among her co-authors are representatives from:
+<WRAP column col4>
+  * [[pharmaceutical_companies:AbbVie]]
+  * [[pharmaceutical_companies:Ablynx]]
+  * [[pharmaceutical_companies:AstraZeneca]]
+  * [[pharmaceutical_companies:BioAgilytix]]
+  * [[pharmaceutical_companies:Biogen]]
+  * [[pharmaceutical_companies:BioMarin]]
+  * [[pharmaceutical_companies:Bluebird Bio]]
+  * [[pharmaceutical_companies:BRI]]
+  * [[Canadian Forum for Analytical and Bioanalytical Sciences]] (CFABS)
+  * [[pharmaceutical_companies:CRISPR Therapeutics]]
+  * [[Food and Drug Administration]] (FDA)
+  * [[pharmaceutical_companies:GlaxoSmithKline]]
+  * [[pharmaceutical_companies:Hexal]]
+  * [[pharmaceutical_companies:Immunologix Labs]]
+  * [[pharmaceutical_companies:Intellia Therapeutics]]
+  * [[pharmaceutical_companies:Janssen]]
+  * [[Medicines & Healthcare products Regulatory Agency]] (MHRA)
+  * [[pharmaceutical_companies:Merck]]
+  * [[Ministry of Health, Labour and Welfare of Japan]] (MHLW)
+  * [[pharmaceutical_companies:Navigate BioPharma]]
+  * [[Norwegian Medicines Agency]]
+  * [[pharmaceutical_companies:Novartis]]
+  * [[pharmaceutical_companies:Novo Nordisk]]
+  * [[pharmaceutical_companies:Pfizer]]
+  * [[pharmaceutical_companies:PPD]]
+  * [[pharmaceutical_companies:Regeneron Pharmaceuticals]]
+  * [[pharmaceutical_companies:Roche]]
+  * [[pharmaceutical_companies:Sangamo Therapeutics]]
+  * [[pharmaceutical_companies:Takeda]]
+</WRAP>
+Zhang was promoted to Senior Clinical Evaluator in March 2021.
+===== Activities =====
+Zhang has participated in research funded by the [[Canadian Institutes of Health Research]] (CIHR).((Zhang, L., Sugamori, K. S., Claridge, C., dela Cruz, A., Grynpas, M. D., & Mitchell, J. (2017). //Overexpression of GαS in Murine Osteoblasts In Vivo Leads to Increased Bone Mass and Decreased Bone Quality.// Journal of Bone and Mineral Research, 32(11), 2171–2181. https://doi.org/10.1002/jbmr.3223))
 ===== External links =====
+  * [[https://covidtruthinitiative.ca/en/Individuals/Lucia-Zhang|COVID Truth Initiative]]
+  * [[https://web.archive.org/web/20230528060056/https://www.ema.europa.eu/sites/default/files/ContactsAndExperts_CVs_and_DOIs/zhang_l20_CV_en.pdf|Curriculum Vitae (European Medicines Agency)]]
   * [[https://www.linkedin.com/in/lucia-zhang-53143226/|LinkedIn]]
+  * [[https://www.researchgate.net/profile/Lucia-Zhang-3|ResearchGate]]